<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04447105</url>
  </required_header>
  <id_info>
    <org_study_id>2003-177-1113</org_study_id>
    <nct_id>NCT04447105</nct_id>
  </id_info>
  <brief_title>Comparison of Postoperative Recovery Between TIVA and Inhalation Agent</brief_title>
  <official_title>Comparison of Recovery After Minimally Invasive Nephrectomy From Inhalation Anesthesia With Desflurane and Total Intravenous Anesthesia With Propofol: a Randomized Single Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized, single-blinded study is designed to compare the postoperative
      quality of recovery between propofol based total intravenous anesthesia and desflurane in
      patients undergoing minimally invasive nephrectomy. We hypothesize that propofol based total
      intravenous anesthesia can significantly improve the quality of recovery after surgery in
      patients with minimally invasive nephrectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adult patients undergoing elective laparoscopic or robotic assisted nephrectomy are randomly
      allocated to receive propofol based total intravenous anesthesia (n=111) or desflurane
      (n=111). The quality of recover after surgery using the QoR-15K was assessed by a
      investigator at postoperative day (POD) 1, 2, and 3. The primary outcome is the QoR-15K at
      POD 1 after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 29, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A prospective randomized single-blinded study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients will receive general anesthesia, therefore they can not know their anesthetic method.
Physicians involved in this study will investigate the outcomes.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>quality of recovery</measure>
    <time_frame>Day 1</time_frame>
    <description>QoR-15K score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of recovery</measure>
    <time_frame>Day 2, 3</time_frame>
    <description>QoR-15K score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain score</measure>
    <time_frame>Day 1, 2, 3</time_frame>
    <description>11-pointed NRS pain score at resting/movement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>Day 1, 2, 3</time_frame>
    <description>Incidence of postoperative nausea and vomiting (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total fentanyl consumption</measure>
    <time_frame>Day 1, 2, 3</time_frame>
    <description>postoperative fentanyl consumption (mcg) via IV patient controlled analgesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">222</enrollment>
  <condition>Enhanced Recovery After Surgery</condition>
  <arm_group>
    <arm_group_label>TIVA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving total intravenous anesthesia with propofol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving inhalation anesthesia with desflurane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total intravenous anesthesia with propofol</intervention_name>
    <description>In the TIVA group, general anesthesia is induced and maintained with a target-controlled infusion of propofol using infusion pump (OrchestraÂ®; Fresenius Vial, Brezins, France). In both groups, remifentanil is continuously infused throughout the surgery for balanced anesthesia, adjusted to maintain arterial pressure.</description>
    <arm_group_label>TIVA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>inhalation anesthesia with desflurane</intervention_name>
    <description>In the desflurane group, anesthesia is induced with propofol 1-2 mg/kg and maintained with desflurane (5-7 vol %). In both groups, remifentanil is continuously infused throughout the surgery for balanced anesthesia, adjusted to maintain arterial pressure.</description>
    <arm_group_label>Desflurane group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo elective laparoscopic or robotic assisted nephrectomy
             under general anesthesia

          -  American Society of Anesthesiologists (ASA) physical classification I-II

          -  Willingness and ability to sign an informed consent document

        Exclusion Criteria:

          -  Do not understand our study

          -  American Society of Anesthesiologists (ASA) physical classification III or more

          -  Allergies to anesthetic or analgesic medications

          -  Chronic pain, chronic analgesic or antidepressant or anticonvulsant use

          -  Medical or psychological disease that can affect the treatment response

          -  Patients who receive mechanical ventilation more than 2 hours after surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hojin Lee, MD</last_name>
    <phone>82-2-2072-2467</phone>
    <email>zenerdiode03@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hyunkyu Yoon, MD</last_name>
    <phone>82-2-2072-2467</phone>
    <email>hyunkyu18@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>KS013</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Lee WK, Kim MS, Kang SW, Kim S, Lee JR. Type of anaesthesia and patient quality of recovery: a randomized trial comparing propofol-remifentanil total i.v. anaesthesia with desflurane anaesthesia. Br J Anaesth. 2015 Apr;114(4):663-8. doi: 10.1093/bja/aeu405. Epub 2014 Dec 10.</citation>
    <PMID>25500679</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 23, 2020</study_first_submitted>
  <study_first_submitted_qc>June 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2020</study_first_posted>
  <last_update_submitted>June 24, 2020</last_update_submitted>
  <last_update_submitted_qc>June 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hojin Lee, MD</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>quality of recovery after surgery</keyword>
  <keyword>anesthetic method</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

